Edwards Lifesciences Corp (EW) Financial Statements (2025 and earlier)
Company Profile
Balance Sheet (Statement of Financial Position) ($ in millions)
| 12/31/2024
| 12/31/2023
| 12/31/2022
| 12/31/2021
| 12/31/2020
| 12/31/2019
| 12/31/2018
|
|
ASSETS |
|
Current Assets |
|
Cash, cash equivalents, and short-term investments | | 1,645 | 1,215 | 1,467 | 1,403 | 1,517 | 957 |
|
Cash and cash equivalent | | 1,144 | 769 | 863 | 1,183 | 1,179 | 714 |
|
Short-term investments | | 501 | 446 | 604 | 219 | 338 | 242 |
|
Restricted cash and investments | | 3 | 1 | 2 | 17 | | |
|
Receivables | | 775 | 643 | 582 | 515 | 544 | 457 |
|
Inventory, net of allowances, customer advances and progress billings | | 1,168 | 876 | 727 | 802 | 641 | 607 |
|
Inventory | | 1,168 | 876 | 727 | 802 | 641 | 607 |
|
Prepaid expense | | 147 | 110 | 85 | 75 | 59 | 54 |
|
Disposal group, including discontinued operation | | | | | | | |
|
Other current assets | | 239 | 196 | 237 | 208 | 168 | 132 |
|
Other undisclosed current assets | | 59 | 56 | 81 | 72 | 56 | 80 |
|
Total current assets: | | 4,036 | 3,096 | 3,181 | 3,091 | 2,984 | 2,287 |
|
Noncurrent Assets |
|
Operating lease, right-of-use asset | | 94 | 92 | 92 | 94 | 80 | ✕ |
|
Property, plant and equipment | | 1,749 | 1,633 | 1,547 | 1,395 | 1,060 | 868 |
|
Long-term investments and receivables | | 584 | 1,239 | 1,834 | 802 | 586 | 506 |
|
Long-term investments | | 584 | 1,239 | 1,834 | 802 | 586 | 506 |
|
Intangible assets, net (including goodwill) | | 1,682 | 1,450 | 1,492 | 1,505 | 1,504 | 1,455 |
|
Goodwill | | 1,254 | 1,164 | 1,168 | 1,173 | 1,168 | 1,112 |
|
Intangible assets, net (excluding goodwill) | | 428 | 285 | 324 | 331 | 337 | 343 |
|
Disposal group, including discontinued operation, noncurrent assets | | | | | | | |
|
Deferred income tax assets | | 755 | 484 | 247 | 231 | 172 | ✕ |
|
Other noncurrent assets | | 464 | 299 | 111 | 120 | 102 | 34 |
|
Other undisclosed noncurrent assets | | | | | | | 174 |
|
Total noncurrent assets: | | 5,328 | 5,197 | 5,322 | 4,146 | 3,504 | 3,037 |
|
TOTAL ASSETS: | | 9,363 | 8,293 | 8,503 | 7,237 | 6,488 | 5,324 |
|
LIABILITIES AND EQUITY |
|
Liabilities |
|
Current Liabilities |
|
Accounts payable and accrued liabilities | | 756 | 625 | 674 | 562 | 647 | 496 |
|
Taxes payable | ✕ | ✕ | ✕ | 31 | 19 | 53 | 31 |
|
Employee-related liabilities | ✕ | ✕ | ✕ | 320 | 237 | 296 | 226 |
|
Accounts payable | | 201 | 202 | 205 | 197 | 180 | 134 |
|
Accrued liabilities | | 554 | 424 | 120 | 110 | 117 | 104 |
|
Debt | | | | | | 26 | |
|
Derivative instruments and hedges, liabilities | | 15 | 21 | 4 | 39 | 6 | 4 |
|
Restructuring reserve | | 12 | 16 | 19 | 15 | 17 | 0 |
|
Estimated litigation liability | | 69 | 53 | | 38 | 20 | 197 |
|
Disposal group, including discontinued operation | | | | | | | |
|
Other undisclosed current liabilities | | 343 | 307 | 335 | 241 | 187 | 180 |
|
Total current liabilities: | | 1,195 | 1,022 | 1,032 | 894 | 902 | 877 |
|
Noncurrent Liabilities |
|
Long-term debt and lease obligation | | 597 | 596 | 665 | 668 | 653 | 594 |
|
Long-term debt, excluding current maturities | | 597 | 596 | 596 | 595 | 594 | 594 |
|
Liabilities, other than long-term debt | | 771 | 724 | 780 | 886 | 548 | 454 |
|
Liability for uncertainty in income taxes | | 339 | 268 | 259 | 214 | 172 | 125 |
|
Estimated litigation liability | | 94 | 143 | 191 | 233 | | |
|
Other liabilities | | 264 | 218 | 267 | 252 | 203 | 150 |
|
Operating lease, liability | | 73 | 70 | 69 | 73 | 59 | ✕ |
|
Business combination, contingent consideration, liability | | | 26 | 62 | 186 | 173 | 179 |
|
Other undisclosed noncurrent liabilities | | 81 | 143 | 190 | | | |
|
Total noncurrent liabilities: | | 1,448 | 1,463 | 1,634 | 1,554 | 1,201 | 1,047 |
|
Total liabilities: | | 2,644 | 2,486 | 2,667 | 2,448 | 2,103 | 1,924 |
|
Equity |
|
Equity, attributable to parent | | 6,650 | 5,807 | 5,836 | 4,574 | 4,148 | 3,140 |
|
Common stock | | 651 | 646 | 642 | 636 | 218 | 215 |
|
Treasury stock, value | | (5,025) | (4,144) | (2,417) | (1,904) | (1,279) | (1,015) |
|
Additional paid in capital | | 2,274 | 1,969 | 1,700 | 1,438 | 1,623 | 1,384 |
|
Accumulated other comprehensive loss | | (243) | (255) | (158) | (161) | (156) | (139) |
|
Retained earnings | | 8,992 | 7,590 | 6,068 | 4,565 | 3,742 | 2,695 |
|
Equity, attributable to noncontrolling interest | | 69 | | | | | |
|
Total equity: | | 6,719 | 5,807 | 5,836 | 4,574 | 4,148 | 3,140 |
|
Other undisclosed liabilities and equity | | | | | 215 | 237 | 259 |
|
TOTAL LIABILITIES AND EQUITY: | | 9,363 | 8,293 | 8,503 | 7,237 | 6,488 | 5,324 |
Income Statement (P&L) ($ in millions)
Comprehensive Income ($ in millions)
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission
(SEC)
through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from
the 10-K and 10-Q reports submitted
to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP
Taxonomy.
Please review the original filings
for a more detailed information.